Bernie,
<<It sounds like you've been peeping at our thread for long enough, that you're now annoyed enough ,to let us know how inadequate we are.
Luckily enough for us, we now have sufficient reason to be ashamed of ourselves for not living up to the expectations of someone whose only contribution is a complaint. Rest assured that we have been eagerly awaiting your input & will look forward to additional learning experiences from you. Bernie.>>
We? OK - Bernie, et al. Sorry, but you missed. I am not the least bit embarrassed at having contributed to this thread by NOT posting when, in fact, I had nothing significant to contribute by doing so. And I will not post hundreds of messages to this board about nothing to establish my right to post here along with the rest of we. Peeping long enough, yes. Annoyed, not really. Not today anyway.
However, I have seen a number of posts recently by people speculating about and wondering how this thread may appear to other investors, particularly people with a new interest in Ligand, and how useful it may be for them as a way to learn about the company and the stock. As I said, I think that most of the effort here is running in a counter-productive vein. I also indicated what I believe is the key to a more successful thread in this case: LESS. If you disagree, fine.
My own experience with LGND and the world of investment message boards is as follows: I came across a post by Henry Niman about LGND on the Motley Fool biotech thread on AOL. I found the MF LGND board and the relatively sparse but, in my view, adequate discussion of the subject there; most of the posts, naturally, by Henry. It sounded good so I purchased some shares (been doing it steadily ever since and have not been disappointed in my expectations.) Later on, I discovered that there was an SI thread full of peanut butter, etc. Not a problem, since Henry and others posted the few items of genuine importance to the MF board. Henry gave up on the MF board to concentrate his energies here; hence, here am I. I appreciate his efforts. However, it is my opinion, for whatever it may be worth, that all of the information essential to a prospective investor in search of background information, pointers to additional sources of information, consensus on company and stock price outlook, (etc.) and even a fair amount of bonhomie, could and would be better dished in fewer servings. Not doing so, in my opinion, wastes a unique and valuable resource.
Well, that's all I have to contribute, so you might have to wait a while if you are expecting additional learning experiences from me. Personally, I was very pleased to learn about sophrosyne today. A few good posts, a few gold nuggets.
Regards,
John |
